- Home
- MIY vs MRVI Comparison
MIY vs MRVI Comparison
Compare MIY & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIY
- MRVI
- Stock Information
- Founded
- MIY 1992
- MRVI 2014
- Country
- MIY United States
- MRVI United States
- Employees
- MIY N/A
- MRVI N/A
- Industry
- MIY Investment Bankers/Brokers/Service
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- MIY Finance
- MRVI Health Care
- Exchange
- MIY Nasdaq
- MRVI Nasdaq
- Market Cap
- MIY 340.0M
- MRVI 347.5M
- IPO Year
- MIY N/A
- MRVI 2020
- Fundamental
- Price
- MIY $11.48
- MRVI $2.16
- Analyst Decision
- MIY
- MRVI Hold
- Analyst Count
- MIY 0
- MRVI 10
- Target Price
- MIY N/A
- MRVI $7.59
- AVG Volume (30 Days)
- MIY 56.8K
- MRVI 3.8M
- Earning Date
- MIY 01-01-0001
- MRVI 05-07-2025
- Dividend Yield
- MIY 3.98%
- MRVI N/A
- EPS Growth
- MIY N/A
- MRVI N/A
- EPS
- MIY N/A
- MRVI N/A
- Revenue
- MIY N/A
- MRVI $259,185,000.00
- Revenue This Year
- MIY N/A
- MRVI N/A
- Revenue Next Year
- MIY N/A
- MRVI $14.59
- P/E Ratio
- MIY N/A
- MRVI N/A
- Revenue Growth
- MIY N/A
- MRVI N/A
- 52 Week Low
- MIY $9.45
- MRVI $2.07
- 52 Week High
- MIY $11.70
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- MIY 51.90
- MRVI 28.06
- Support Level
- MIY $11.23
- MRVI $2.07
- Resistance Level
- MIY $11.43
- MRVI $2.43
- Average True Range (ATR)
- MIY 0.09
- MRVI 0.20
- MACD
- MIY -0.00
- MRVI 0.05
- Stochastic Oscillator
- MIY 73.53
- MRVI 14.06
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from federal and Michigan income taxes.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.